Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036153982> ?p ?o ?g. }
- W3036153982 abstract "ABSTRACT Background: Amyloid pathology, which is one of the characteristics of Alzheimer’s disease (AD), results from altered metabolism of the beta-amyloid peptide (Aβ) in terms of synthesis, clearance or aggregation. A decrease in cerebrospinal fluid (CSF) level Aβ 1-42 is evident in AD, and the CSF ratio Aβ 40 /Aβ 40 has recently been identified as one of the most reliable diagnostic biomarkers of amyloid pathology. Variations in inter-individual levels of Aβ 1-40 in the CSF have been observed in the past, but their origins remain unclear. In addition, the variation of Aβ 40 in the context of AD studied in several studies has yielded conflicting results. Methods Here, we analyzed the levels of Aβ 1-40 using multicenter data obtained on 2466 samples from six different cohorts in which CSF was collected under standardized protocols, centrifugation and storage conditions. Tau and p-tau(181) concentrations were measured using commercially available in vitro diagnostic immunoassays. Concentrations of CSF Aβ 1-42 and Aβ 1-40 were measured by ELISA, xMAP technology, chemiluminescence immunoassay (CLIA) and mass spectrometry. Statistical analyses were calculated for parametric and non-parametric comparisons, linear regression, correlation and odds ratios. The statistical tests were adjusted for the effects of covariates (age, in particular). Results: Regardless of the analysis method used and the cohorts, a slight but significant age-independent increase in the levels of Aβ 40 in CSF was observed in AD. We also found a strong positive correlation between the levels of Aβ 40 and p-tau(181) in CSF, particularly in control patients. Conclusions: These results indicate that an increase in the baseline level of amyloid peptides, which are associated with an increase in p-tau(181), may be a biological characteristic of AD. This confirms the potential therapeutic value of lowering the baseline levels of Aβ 40 which, being elevated, can be considered a risk factor for the disease." @default.
- W3036153982 created "2020-06-25" @default.
- W3036153982 creator A5004287617 @default.
- W3036153982 creator A5009282279 @default.
- W3036153982 creator A5010797490 @default.
- W3036153982 creator A5012378779 @default.
- W3036153982 creator A5018392451 @default.
- W3036153982 creator A5020794941 @default.
- W3036153982 creator A5026244795 @default.
- W3036153982 creator A5027936436 @default.
- W3036153982 creator A5036923699 @default.
- W3036153982 creator A5041337674 @default.
- W3036153982 creator A5045456582 @default.
- W3036153982 creator A5046188463 @default.
- W3036153982 creator A5049589460 @default.
- W3036153982 creator A5065534638 @default.
- W3036153982 creator A5069686312 @default.
- W3036153982 creator A5076007777 @default.
- W3036153982 creator A5089399854 @default.
- W3036153982 date "2020-06-02" @default.
- W3036153982 modified "2023-10-17" @default.
- W3036153982 title "Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals" @default.
- W3036153982 cites W1208364757 @default.
- W3036153982 cites W128824458 @default.
- W3036153982 cites W1776172174 @default.
- W3036153982 cites W1809995503 @default.
- W3036153982 cites W1968352263 @default.
- W3036153982 cites W1969271586 @default.
- W3036153982 cites W1980314710 @default.
- W3036153982 cites W1986748953 @default.
- W3036153982 cites W2006409771 @default.
- W3036153982 cites W2010528085 @default.
- W3036153982 cites W2019875409 @default.
- W3036153982 cites W2041245991 @default.
- W3036153982 cites W2044513730 @default.
- W3036153982 cites W2060492349 @default.
- W3036153982 cites W2071910392 @default.
- W3036153982 cites W2073171431 @default.
- W3036153982 cites W2082429191 @default.
- W3036153982 cites W2090220280 @default.
- W3036153982 cites W2090523774 @default.
- W3036153982 cites W2092635152 @default.
- W3036153982 cites W2104583741 @default.
- W3036153982 cites W2104954974 @default.
- W3036153982 cites W2108475007 @default.
- W3036153982 cites W2109135047 @default.
- W3036153982 cites W2111200377 @default.
- W3036153982 cites W2115017507 @default.
- W3036153982 cites W2116709840 @default.
- W3036153982 cites W2125380849 @default.
- W3036153982 cites W2133360097 @default.
- W3036153982 cites W2136936410 @default.
- W3036153982 cites W2139778458 @default.
- W3036153982 cites W2144647267 @default.
- W3036153982 cites W2146618600 @default.
- W3036153982 cites W2146636364 @default.
- W3036153982 cites W2156220037 @default.
- W3036153982 cites W2158945984 @default.
- W3036153982 cites W2162997750 @default.
- W3036153982 cites W2168283959 @default.
- W3036153982 cites W2170392978 @default.
- W3036153982 cites W2207877462 @default.
- W3036153982 cites W2226005455 @default.
- W3036153982 cites W2236825227 @default.
- W3036153982 cites W2327547544 @default.
- W3036153982 cites W2529926589 @default.
- W3036153982 cites W2590478248 @default.
- W3036153982 cites W2593953154 @default.
- W3036153982 cites W2610587026 @default.
- W3036153982 cites W2615911550 @default.
- W3036153982 cites W2785757836 @default.
- W3036153982 cites W2789976306 @default.
- W3036153982 cites W2794074331 @default.
- W3036153982 cites W2801831966 @default.
- W3036153982 cites W2802918776 @default.
- W3036153982 cites W2883021501 @default.
- W3036153982 cites W2884160653 @default.
- W3036153982 cites W2904722354 @default.
- W3036153982 cites W2945980668 @default.
- W3036153982 cites W2948100499 @default.
- W3036153982 cites W3012272172 @default.
- W3036153982 cites W4211156109 @default.
- W3036153982 cites W74129954 @default.
- W3036153982 doi "https://doi.org/10.1101/2020.06.02.20119578" @default.
- W3036153982 hasPublicationYear "2020" @default.
- W3036153982 type Work @default.
- W3036153982 sameAs 3036153982 @default.
- W3036153982 citedByCount "0" @default.
- W3036153982 crossrefType "posted-content" @default.
- W3036153982 hasAuthorship W3036153982A5004287617 @default.
- W3036153982 hasAuthorship W3036153982A5009282279 @default.
- W3036153982 hasAuthorship W3036153982A5010797490 @default.
- W3036153982 hasAuthorship W3036153982A5012378779 @default.
- W3036153982 hasAuthorship W3036153982A5018392451 @default.
- W3036153982 hasAuthorship W3036153982A5020794941 @default.
- W3036153982 hasAuthorship W3036153982A5026244795 @default.
- W3036153982 hasAuthorship W3036153982A5027936436 @default.
- W3036153982 hasAuthorship W3036153982A5036923699 @default.
- W3036153982 hasAuthorship W3036153982A5041337674 @default.
- W3036153982 hasAuthorship W3036153982A5045456582 @default.